MRx maps brain biomarkers in noncontrast MRI scan
University of Illinois researchers developed multiplexed MRI to map more than 20 brain biomarkers in a single scan using standard clinical MRI systems.

University of Illinois Urbana-Champaign researchers have developed multiplexed MRI, an acquisition and processing method that can map more than 20 brain biomarkers in a single noncontrast scan. The work was published in Nature.
MRx uses an AI-powered framework to produce high-resolution multiparametric maps of structural, physiological, and molecular brain markers. Researchers demonstrated the technique in brain tumors and multiple sclerosis lesions.
A whole-brain MRx scan can be completed in approximately 14 minutes, according to the university. Researchers said that is within a clinically acceptable time frame and shorter than conventional multicontrast clinical MRI protocols, which can take up to 1 hour.
Nature’s abstract states that MRx can obtain a large set of quantitative biomarkers of the whole brain in standard clinical settings. The authors also reported that these biomarkers could define a tissue state index for disease subtyping and lesion characterization in tumors and MS.
Rong Guo, PhD, a coauthor and senior scientist at Siemens Healthineers, said MRx measures multiple markers “without the need for contrast agents.”
University researchers said the biomarkers provide information related to tissue metabolism, neurotransmission, physiological function, and structural characteristics. The technique may support research into early detection, diagnosis, prognosis, and treatment monitoring for brain diseases, according to the university.
The study, “Multiplexed magnetic resonance imaging,” was authored by Yudu Li, Rong Guo, Yibo Zhao, Wen Jin, Ziwen Ke, Liang Chen, Xiangjun Chen, Weijun Tang, Yao Li, and Zhi-Pei Liang.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

Quantum reports early results from MS PET study
The ongoing MGH study is evaluating [18F]3F4AP PET imaging for demyelinated neurons with intact axons in patients with multiple sclerosis.

Cochrane updates prostate cancer screening review
The updated review found PSA screening likely reduces prostate cancer deaths, but evidence remains unclear for newer screening strategies combining PSA, kallikrein testing, and MRI.

Stage 4 breast cancer diagnoses rise over decade
A cohort study of 761,471 people found de novo stage 4 breast cancer incidence increased by 1.2% per year from 2010 to 2021.